Clinical assessment of ChAdOx1 vectored vaccines against emerging pathogens
<p>Traditional vaccine development strategies are costly and time-consuming which makes them unsuitable for clinical assessment of new vaccines in the context of infectious diseases outbreaks. Platform technologies provide substantial manufacturing advantages and have the potential to signific...
Main Author: | Moreira Folegatti, P |
---|---|
Other Authors: | Gilbert, S |
Format: | Thesis |
Language: | English |
Published: |
2021
|
Subjects: |
Similar Items
-
Stability of Chimpanzee Adenovirus Vectored Vaccines (ChAdOx1 and ChAdOx2) in Liquid and Lyophilised Formulations
by: Adam Berg, et al.
Published: (2021-10-01) -
Effect of Prior ChAdOx1 COVID-19 Immunisation on T-Cell Responses to ChAdOx1-HBV
by: Charlotte Davis, et al.
Published: (2024-06-01) -
Lyophilization to enable distribution of ChAdOx1 and ChAdOx2 adenovirus-vectored vaccines without refrigeration
by: Zhang, C, et al.
Published: (2023) -
Lyophilization to enable distribution of ChAdOx1 and ChAdOx2 adenovirus-vectored vaccines without refrigeration
by: Cheng Zhang, et al.
Published: (2023-06-01) -
An exploratory analysis of the response to ChAdOx1 nCoV-19 (AZD1222) vaccine in males and females
by: Natalie Gabrielle Marchevsky, et al.
Published: (2022-07-01)